Comments on: Fangda Assisted Laekna in Entering into an Exclusive Licensing Agreement with Qilu Pharma for LAE002 (AFURESERTIB) in China

Comments on: Fangda Assisted Laekna in Entering into an Exclusive Licensing Agreement with Qilu Pharma for LAE002 (AFURESERTIB) in China /press-release/fangda-laekna-qilu-pharma/ Tue, 25 Nov 2025 07:21:11 +0000 hourly 1